Loading candles…
Alkali Metals Ltd, incorporated in 1968, operates in the chemical manufacturing and pharmaceutical intermediates industries. The company specializes in producing alkali metal derivatives, specialty chemicals, and pharmaceutical intermediates, primarily serving pharmaceutical and fine chemical applications. Its business segments include manufacturing sodium derivatives, pyridine derivatives, fine chemicals, and APIs. The product portfolio features sodium derivatives such as sodium amide, sodium alkoxides, sodium hydride, and sodium azide, as well as tetrazoles and amino pyridines. Alkali Metals Ltd is an ISO 9001 and ISO 14001 certified entity and is recognized as an export house. No information is provided regarding founders, key management, geographic presence, subsidiaries, notable projects, or stock exchange listings.
This page is a live market overview for ALKALI METALS LTD (ALKALI) on the NSE. As a listed security, ALKALI METALS LTD is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ALKALI before placing trades on tick2trade.
As of the latest feed, ALKALI last traded at ₹103.2 on NSE, up ₹0 (0.00%) from the previous close of ₹103.2. Today's session range is ₹0 – ₹0, against a 52-week band of ₹46.8 – ₹107.38. Traded volume today stands at 2.52L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for ALKALI in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ALKALI is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ALKALI METALS LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ALKALI. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ALKALI option chain page linked from this overview.
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | 20 Jul 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters | 26 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 14 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 and other business matters | 7 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters | 18 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters | 19 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.